Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Free Cash Flow (2021 - 2025)

Core Scientific's Free Cash Flow history spans 5 years, with the latest figure at -$121.7 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 252.6% year-over-year to -$121.7 million; the TTM value through Dec 2025 reached -$450.8 million, down 1156.49%, while the annual FY2025 figure was -$450.8 million, 1156.49% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$121.7 million at Core Scientific, up from -$317.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $225.8 million in Q4 2021 and bottomed at -$317.9 million in Q3 2025.
  • The 5-year median for Free Cash Flow is $6.4 million (2023), against an average of -$13.7 million.
  • The largest annual shift saw Free Cash Flow plummeted 3039.59% in 2022 before it surged 1150.03% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $225.8 million in 2021, then crashed by 48.62% to $116.0 million in 2022, then plummeted by 94.5% to $6.4 million in 2023, then soared by 1150.03% to $79.8 million in 2024, then tumbled by 252.6% to -$121.7 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Free Cash Flow are -$121.7 million (Q4 2025), -$317.9 million (Q3 2025), and $117.9 million (Q2 2025).